Methyldopa can be safely discontinued if tapered gradually over 2 weeks to avoid rebound hypertension. Monitor BP closely and transition to new therapy concurrently.

To minimize withdrawal effects, methyldopa should be tapered rather than stopped abruptly. Adjust the taper schedule based on the patient’s response and the new medication regimen.